<div id="readability-page-1"><p>Westover Capital Advisors LLC grew its holdings in shares of  Cardinal Health, Inc. (NYSE:CAH - Free Report) by 75.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 4,262 shares of the company's stock after purchasing an additional 1,837 shares during the period. Westover Capital Advisors LLC's holdings in Cardinal Health were worth $716,000 as of its most recent SEC filing.</p><ul><li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li></ul><p>Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP raised its stake in  Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after buying an additional 2,249,241 shares during the last quarter.  JPMorgan Chase &amp; Co. grew its stake in shares of  Cardinal Health by 40.0% in the first quarter. JPMorgan Chase &amp; Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter.  Zurich Insurance Group Ltd FI increased its holdings in shares of  Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock valued at $130,434,000 after acquiring an additional 927,950 shares in the last quarter.  Acadian Asset Management LLC raised its position in shares of  Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company's stock worth $282,063,000 after purchasing an additional 807,063 shares during the last quarter.  Finally, Nuveen LLC bought a new position in  Cardinal Health in the 1st quarter worth about $106,065,000. Hedge funds and other institutional investors own  87.17% of the company's stock. </p><div><p><span></span><span>Get <strong>Cardinal Health</strong> alerts:</span></p></div><h2>Analyst Upgrades and Downgrades</h2><p>CAH has been the topic of several recent analyst reports. Morgan Stanley  reissued an &#34;overweight&#34; rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Mizuho increased their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the company an &#34;outperform&#34; rating in a report on Monday, November 3rd. Evercore ISI raised their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 31st. Wells Fargo &amp; Company upped their price objective on Cardinal Health from $185.00 to $221.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 5th. Finally, Leerink Partners lifted their target price on Cardinal Health from $211.00 to $230.00 and gave the stock an &#34;outperform&#34; rating in a report on Monday. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $206.46.</p><ul><li>Medical Technology Stock Benefits from Rising Acute Care Demand</li></ul><p><b>Get Our Latest Stock Analysis on CAH</b></p><h2>Insider Buying and Selling</h2><p>In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the transaction, the chief executive officer owned 200,000 shares of the company's stock, valued at approximately $30,008,000. This represents a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Company insiders own  0.12% of the company's stock. </p><h2>Cardinal Health Stock Up 0.4%</h2><ul><li>For Cardinal Health, the Proof Will be in Its Performance</li></ul><p>CAH opened at $206.25 on Tuesday. The stock has a market capitalization of $49.00 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 1.39 and a beta of 0.72. The firm has a 50 day moving average price of $166.70 and a 200-day moving average price of $159.64. Cardinal Health, Inc. has a twelve month low of $114.60 and a twelve month high of $208.32. </p><p>Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts' consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's revenue was up 22.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.88 EPS.  Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts expect that  Cardinal Health, Inc. will post 7.95 earnings per share for the current year. </p><h2>Cardinal Health Announces Dividend</h2><p>The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health's payout ratio is presently 30.77%. </p><h2>Cardinal Health Profile</h2> (Free Report)<p>Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Cardinal Health</li><li>Consumer Discretionary Stocks Explained</li><li>Seagate Stock Could Soar as AI Drives Storage Demand</li><li>ETF Screener: Uses and Step-by-Step Guide </li><li>Whirlpool’s Worst May Be Over—Upside Opportunity Ahead</li><li>Upcoming IPO Stock Lockup Period, Explained</li><li>These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter</li></ul><p><strong>Want to see what other hedge funds are holding CAH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2><p>Before you consider Cardinal Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Westover Capital Advisors LLC increased its holdings in Cardinal Health, Inc. by 75.8% in Q2, now owning 4,262 shares valued at $716,000. Other institutional investors also adjusted their positions, with significant increases from Wellington Management, JPMorgan Chase, and Zurich Insurance. Analysts have given Cardinal Health a "Moderate Buy" rating, with a consensus price target of $206.46. The stock opened at $206.25, with a market cap of $49 billion. Recent earnings exceeded expectations, with revenue up 22.4% year-over-year.</p>

Westover Capital Advisors LLC Acquires 1,837 Shares of Cardinal Health, Inc. $CAH